Loading
Latest filing published 23 Feb 2026 for Silexion Therapeutics Corp.
No signal scores available.
Ruth Alon is a declared insider of Silexion Therapeutics Corp, with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 9 February 2025 to 20 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 23 February 2026, the filings show a share grant in Silexion Therapeutics Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.